Endocrine, Metabolic & Immune Disorders - Drug Targets(Formerly Current Dru

The Protective Function of Human C-reactive Protein in Mouse Models of Streptococcus pneumoniae Infection
pp. 231-237(7)
Authors: Agrawal, Alok; Suresh, Madathilparambil V.; Singh, Sanjay K.; Ferguson Jr., Donald A.

Further LDL Cholesterol Lowering Through Targeting PCSK9 for Coronary Artery Disease
pp. 238-243(6)
Authors: Cao, Guoqing; Qian, Yue-Wei; Kowala, Mark C.; Konrad, Robert J.

The Adenosine A2b Receptor: Its Role in Inflammation
pp. 244-254(11)
Authors: Ham, J.; Rees, D. A.

Emerging Roles for the CD36 Scavenger Receptor as a Potential Therapeutic Target for Corneal Neovascularization
pp. 255-272(18)
Authors: Mwaikambo, B. R.; Yang, C.; Ong, H.; Chemtob, S.; Hardy, P.

Src as a Therapeutic Target in Breast Cancer
pp. 273-278(6)
Authors: Morgan, Liam; Nicholson, Robert I.; Hiscox, Stephen

The Role of Negative Costimulators During Parasitic Infections
pp. 279-288(10)
Authors: Lepenies, Bernd; Jacobs, Thomas

Roles of Retinoic Acid in Induction of Immunity and Immune Tolerance
pp. 289-294(6)
Author: Kim, Chang H.

Future Targets for Immune Therapy in Colitis?
pp. 295-300(6)
Authors: Kristensen, N. N.; Claesson, M. H.

Does Non-Alcoholic Fatty Liver Disease (NAFLD) Increase Cardiovascular Risk?
pp. 301-307(7)
Authors: Montecucco, Fabrizio; Mach, Francois

Tissue Factor Modulation by Angiotensin II: A Clue to a Better Understanding of the Cardiovascular Effects of Renin-Angiotensin System Blockade?
pp. 308-313(6)
Authors: Celi, Alessandro; Fiorentino, Alessandra D.; Cianchetti, Silvana; Pedrinelli, Roberto